Company / Working Capital per Share
MADRIGAL PHARMACEUTICALS, INC. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$42.51
FY2025
5-year range
$12.56 / $43.45
FY2021-FY2025
Trend
-2.2%
vs FY2024
Sector context
#7 of 210
Health Care
What the data says
Among 210 Health Care companies, MADRIGAL PHARMACEUTICALS, INC. is in the top 3% for working capital per share. Working Capital per Share has fluctuated over the past 10 years, ranging from $7.00 in FY2016 to $43.45 in FY2024.
Based on SEC 10-K filings.
42.51 in FY2025 with a 5-year CAGR of +22.4%. Top quartile in the Health Care sector.
Improved from $28.66 to $42.51 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +43.7%
- 5-Year CAGR
- +22.4%
- 10-Year CAGR
- -
Sector benchmark
-71.1% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 2.2% year-over-year.
- Ranks #7 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2024.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $42.51 | -2.2% |
| FY2024 | $43.45 | +51.6% |
| FY2023 | $28.66 | +100.0% |
| FY2022 | $14.32 | +14.0% |
| FY2021 | $12.56 | -18.8% |
| FY2020 | $15.46 | -42.6% |
| FY2019 | $26.96 | -16.3% |
| FY2018 | $32.22 | +116.8% |
| FY2017 | $14.86 | +112.4% |
| FY2016 | $7.00 | +770.9% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026